Interstitial 22q13 deletions: Genes other than SHANK3 have major effects on cognitive and language development

European Journal of Human Genetics

Volumn 16, Issue 11, 2008, Pages 1301-1310

  Wilson, Heather L ^a   Crolla, John A ^b   Walker, Dena ^c   Artifoni, Lina ^d   Dallapiccola, Bruno ^e   Takano, Takako ^f   Vasudevan, Pradeep ^c   Huang, Shuwen ^b   Maloney, Vivienne ^b   Yobb, Twila ^a   Quarrell, Oliver ^c   McDermid, Heather E ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b SALISBURY DISTRICT HOSPITAL   (United Kingdom)

^c SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF PADOVA   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f TOKYO KASEI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SHANK3 PROTEIN; STRUCTURAL PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; CHILD; CHROMOSOME 22Q; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION; CLINICAL FEATURE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DUPLICATION; GENE FREQUENCY; GENE LOCATION; GENE LOSS; HAPLOTYPE; HEARING LOSS; HETEROZYGOTE; HUMAN; MENTAL DEFICIENCY; MICROCHROMOSOME; MICROSATELLITE MARKER; MUSCLE HYPOTONIA; PHENOTYPIC VARIATION; PRIORITY JOURNAL; SPEECH DELAY; SPEECH DISORDER;

CARRIER PROTEINS; CHILD; CHROMOSOMES, HUMAN, PAIR 22; GENE DELETION; HUMANS; INFANT; LANGUAGE DEVELOPMENT DISORDERS; MALE; MENTAL RETARDATION; SYNDROME;

EID: 54549096891     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2008.107     Document Type: Article

References (23)

1. Koolen DA, Reardon W, Rosser EM et al: Molecular characterisation of patients with subtelomeric 22q abnormalities using chromosome specific array-based comparative genomic hybridisation. Eur J Hum Genet 2005; 13: 1019-1024.
2. Lindquist SG, Kirchhoff M, Lundsteen C et al: Further delineation of the 22q13 deletion syndrome. Clin Dysmorphol 2005; 14: 55-60.
3. Luciani JJ, de Mas P, Depetris D et al: Telomeric 22q13 deletions resulting from rings, simple deletions, and translocations: Cytogenetic, molecular, and clinical analyses of 32 new observations. J Med Genet 2003; 40: 690-696.
4. Manning MA, Cassidy SB, Clericuzio C et al: Terminal 22q deletion syndrome: A newly recognized cause of speech and language disability in the autism spectrum. Pediatrics 2004; 114: 451-457.
5. Phelan MC, Rogers RC, Saul RA et al: 22q13 deletion syndrome. Am J Med Genet 2001; 101: 91-99.
6. Wilson HL, Wong ACC, Shaw SR et al: Molecular characterization of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms. J Med Genet 2003; 40: 575-584.
7. Havens JM, Visootsak J, Phelan MC, Graham Jr JM: 22q13 deletion syndrome: An update and review for the primary pediatrician. Clin pediatr 2004; 43: 43-53.
8. Anderlid BM, Schoumans J, Anneren G et al: FISH-mapping of a 100-kb terminal 22q13 deletion. Hum Genet 2002; 110: 439-443.
9. Bonaglia MC, Giorda R, Mani E et al: Identification of a recurrent breakpoint within the SHANK3 gene in the 22q13.3 deletion syndrome. J Med Genet 2006; 43: 822-828.
10. Wong AC, Ning Y, Flint J et al: Molecular characterization of a 130-kb terminal microdeletion at 22q in a child with mild mental retardation. Am J Hum Genet 1997; 60: 113-120.
11. Bonaglia MC, Giorda R, Borgatti R et al: Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome. Am J Hum Genet 2001; 69: 261-268.
12. Durand CM, Betancur C, Boeckers TM et al: Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet 2007; 39: 25-27.
13. Moessner R, Marshall CR, Sutcliffe JS et al: Contribution of SHANK3 mutations to autism spectrum disorder. Am J Hum Genet 2007; 81: 1289-1297.
14. Romain DR, Goldsmith J, Cairney H, Columbano-Green LM, Smythe RH, Parfitt RG: Partial monosomy for chromosome 22 in a patient with del(22)(pter - q13.1::Q13.33 - qter). J Med Genet 1990; 27: 588-589.
15. Fujita Y, Mochizuki D, Mori Y et al: Girl with accelerated growth, hearing loss, inner ear anomalies, delayed myelination of the brain, and del(22)(q13.1q13.2). Am J Med Genet 2000; 92: 195-199.
16. Nesslinger NJ, Gorski JL, Kurczynski TW et al: Clinical, cytogenetic, and molecular characterization of seven patients with deletions of chromosome 22q13.3. Am J Hum Genet 1994; 54: 464-472.
17. McTaggart KE, Budarf ML, Driscoll DA, Emanuel BS, Ferreira P, McDermid HE: Cat eye syndrome chromosome breakpoint clIstering: identification of two intervals also associated with 22q11 deletion syndrome breakpoints. Cytogenet Cell Genet 1998; 81: 222-228.
18. Armour JA, Povey S, Jeremiah S, Jeffreys AJ: Systematic cloning of human minisatellites from ordered array charomid libraries. Genomics 1990; 8: 501-512.
19. Sambrook J, Russell DW: Molecular Cloning: A Laboratory Manual, 3rd edn. Cold Spring Harbor, New York. Cold Spring Harbor Laboratory Press, 2001.
20. Church GM, Gilbert W: Genomic sequencing. Proc Natl Acad Sci USA 1984; 81: 1991-1995.
21. Yobb TM, Somerville MJ, Willatt L et al: Microduplication and triplication of 22q11.2: A highly variable syndrome. Am J Hum Genet 2005; 76: 865-876.
22. Cockwell AE, Jacobs PA, Crolla JA: Distribution of the D15Z1 copy number polymorphism. Eur J Hum Genet 2007; 15: 441-445.
23. Boeckers TM, Winter C, Smalla KH et al: Proline-rich synapse-associated proteins ProSAP1 and ProSAP2 interact with synaptic proteins of the SAPAP/GKAP family. Biochem Biophys Res Commun 1999b; 264: 247-252.